Stephen Pyon is a Research Associate II at Skylark Bio, where he focuses on in-house process development and the buildout and optimization of the company’s manufacturing capabilities. He started his career with AAV upstream process development at Modalis Therapeutics and most recently supported production, process development and analytics on the Vector Core at nChroma Bio. He brings a strong background in AAV and other viral vector process development. Stephen earned a Bachelor of Science in Biomedical Engineering and Computer Science from Brown University and joined Skylark Bio in January 2026.